Brand Name

Dolobid

Generic Name
Diflunisal
View Brand Information
FDA approval date: March 08, 2012
Classification: Nonsteroidal Anti-inflammatory Drug
Form: Tablet

What is Dolobid (Diflunisal)?

Carefully consider the potential benefits and risks of Dolobid and other treatment options before deciding to use Dolobid. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals. Dolobid is indicated for acute or long-term use for symptomatic treatment of the following: Mild to moderate pain Osteoarthritis Rheumatoid arthritis.
Save this treatment for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms

Related Clinical Trials

There is no clinical trials being done for this treatment

Related Latest Advances

Guidelines for the management of hereditary ATTR amyloidosis 2026.
Efficacy of diflunisal for hereditary transthyretin amyloidosis: the Swedish real-world experience.